These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 27456700)
1. Evaluation of potential drug- drug interactions among Palestinian hemodialysis patients. Al-Ramahi R; Raddad AR; Rashed AO; Bsharat A; Abu-Ghazaleh D; Yasin E; Shehab O BMC Nephrol; 2016 Jul; 17():96. PubMed ID: 27456700 [TBL] [Abstract][Full Text] [Related]
2. Prevalence and pattern of potential drug-drug interactions among chronic kidney disease patients in south-western Nigeria. Olumuyiwa JF; Akinwumi AA; Ademola OA; Oluwole BA; Ibiene EO Niger Postgrad Med J; 2017; 24(2):88-92. PubMed ID: 28762362 [TBL] [Abstract][Full Text] [Related]
3. Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of Drugs. Busa G; Burlina A; Damuzzo V; Chiumente M; Palozzo AC J Pharm Pract; 2018 Feb; 31(1):58-65. PubMed ID: 29278992 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of the coprescription of clinically important interacting drug combinations involving oral anticancer agents in Singapore: a retrospective database study. Ko Y; Tan SL; Chan A; Wong YP; Yong WP; Ng RC; Lim SW; Salim A Clin Ther; 2012 Aug; 34(8):1696-704. PubMed ID: 22795926 [TBL] [Abstract][Full Text] [Related]
5. Polypharmacy, aging and potential drug-drug interactions in outpatients in Taiwan: a retrospective computerized screening study. Lin CF; Wang CY; Bai CH Drugs Aging; 2011 Mar; 28(3):219-25. PubMed ID: 21250763 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of drug-drug interactions among patients with chronic kidney disease in a South-Eastern Nigeria tertiary hospital: a retrospective study. Adibe MO; Ewelum PC; Amorha KC Pan Afr Med J; 2017; 28():199. PubMed ID: 29610637 [TBL] [Abstract][Full Text] [Related]
7. Assessing Drug-Drug Interaction Potential among Patients Admitted to Surgery Departments in Three Palestinian Hospitals. Rabba AK; Abu Hussein AM; Abu Sbeih BK; Nasser SI Biomed Res Int; 2020; 2020():9634934. PubMed ID: 33029535 [TBL] [Abstract][Full Text] [Related]
8. Assessment of prescribed medications and pattern of distribution for potential drug-drug interactions among chronic kidney disease patients attending the Nephrology Clinic of Lagos University Teaching Hospital in Sub-Saharan West Africa. Fasipe OJ; Akhideno PE; Nwaiwu O; Adelosoye AA Clin Pharmacol; 2017; 9():125-132. PubMed ID: 29123429 [TBL] [Abstract][Full Text] [Related]
9. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Doan J; Zakrzewski-Jakubiak H; Roy J; Turgeon J; Tannenbaum C Ann Pharmacother; 2013 Mar; 47(3):324-32. PubMed ID: 23482734 [TBL] [Abstract][Full Text] [Related]
10. The prevalence of potential drug-drug interactions in patients with heart failure at hospital discharge. Straubhaar B; Krähenbühl S; Schlienger RG Drug Saf; 2006; 29(1):79-90. PubMed ID: 16454536 [TBL] [Abstract][Full Text] [Related]
11. [Hypertension in hemodialysis patients in Andalucia]. García Cortés MJ; Ceballos M; Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of contraindications and prescription of pharmacologic therapies for gout. Keenan RT; O'Brien WR; Lee KH; Crittenden DB; Fisher MC; Goldfarb DS; Krasnokutsky S; Oh C; Pillinger MH Am J Med; 2011 Feb; 124(2):155-63. PubMed ID: 21295195 [TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of drug-drug interactions in hospitalized dermatology patients. Ganeva M; Gancheva T; Troeva J; Kiriyak N; Hristakieva E Adv Clin Exp Med; 2013; 22(4):555-63. PubMed ID: 23986216 [TBL] [Abstract][Full Text] [Related]
14. Relation between number of prescribed medication and outcome in peritoneal dialysis patients. Szeto CC; Chow KM; Kwan BC; Leung CB; Chung KY; Law MC; Li PK Clin Nephrol; 2006 Oct; 66(4):256-62. PubMed ID: 17063992 [TBL] [Abstract][Full Text] [Related]
15. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Johnell K; Klarin I Drug Saf; 2007; 30(10):911-8. PubMed ID: 17867728 [TBL] [Abstract][Full Text] [Related]
16. Identifying and Communicating Clinically Meaningful Drug-Drug Interactions. Nelson SD; LaFleur J; Hunter E; Archer M; Steinvoort C; Maden C; Oderda GM J Pharm Pract; 2016 Apr; 29(2):110-5. PubMed ID: 25107417 [TBL] [Abstract][Full Text] [Related]
17. The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients. Rosas-Carrasco O; García-Peña C; Sánchez-García S; Vargas-Alarcón G; Gutiérrez-Robledo LM; Juárez-Cedillo T Rev Invest Clin; 2011; 63(6):564-73. PubMed ID: 23650669 [TBL] [Abstract][Full Text] [Related]
18. [Cardiovascular risk in hemodialysis in Spain: prevalence, management and target results (MAR study)]. Portolés J; López-Gómez JM; Aljama P Nefrologia; 2005; 25(3):297-306. PubMed ID: 16053011 [TBL] [Abstract][Full Text] [Related]
19. The epidemiology of stroke in northern palestine: a 1-year, hospital-based study. Sweileh WM; Sawalha AF; Al-Aqad SM; Zyoud SH; Al-Jabi SW J Stroke Cerebrovasc Dis; 2008; 17(6):406-11. PubMed ID: 18984436 [TBL] [Abstract][Full Text] [Related]
20. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database. Tuchscherer RM; Nair K; Ghushchyan V; Saseen JJ Am J Cardiovasc Drugs; 2015 Feb; 15(1):27-34. PubMed ID: 25348907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]